PROFESSOR JOHN IDOKO MD, FMCP
John Idoko trained in internal medicine, infectious diseases and immunology of infections and has been an HIV physician since 1995. He is currently the Director General of the National Agency for the Control of AIDS (NACA).
He was Principal Investigator of the Harvard University/AIDS Prevention Initiative Nigeria (APIN) Presidential Emergency Plan for AIDS Relief (PEPFAR0 program at the Jos University Teaching Hospital (JUTH). The antiretroviral clinic (ART) at JUTH cares for about 12,000 patients with HIV representing one of the largest clinics in Nigeria. The program in JUTH pioneered the “Hub and Spoke” network of decentralized and integrated services delivering comprehensive HIV services TB, Malaria and sexual and reproductive health which is now widely implemented in Nigeria.
Professor Idoko was President Nigerian AIDS Research Network, Chairman Nigerian National Antiretroviral Committee and. He was Deputy Vice-Chancellor of the University of Jos (1994-1998). He is Co-Chair of the newly established West African Infectious Diseases Institute (WAIDI) and serves on several boards including the Governing Council of the International AIDS Society (IAS).
His research interests include clinical trials of antiretroviral drugs, adherence to ART, Tuberculosis, hepatitis co-infection, resistance to ART, social and behaviour issues in HIV and models for scaling out comprehensive HIV services. He has over 70 publications in peer reviewed journals and contributed to several books.
Prof Sulaimon Akanmu
Sulaimon Akanmu is a Professor of haematology and blood transfusion at the College of Medicine, University of Lagos (LUTH), Nigeria and the Principal Investigator for the APIN HIV Care and Treatment Programme in LUTH, a clinic with over 7,000 adult patients on ART.
He has over 10 years’ experience in HIV medicine and is the current chairman of the National ART task team in Nigeria. He is also the secretary of the African Society for Blood Transfusion (AfSBT) West African sub region, and the President of the Nigeria Society for Haematology and Blood transfusion (NSHBT).
He is a seasoned researcher with over 74 publications in local and international journals with over 30 oral presentations at local and international scientific meetings.
Dr Mustapha Gidado
Dr Gidado is a public health physician with over 13 years of Tuberculosis specific experience. In addition to an MPH degree, he has an International Master Degree in Health professional Education (MeEdu) from Maastricht University, The Netherlands.
He worked at the National TB & Leprosy Training Center, Zaria for over 10 years, and was a zonal coordinator for TB & Leprosy Control for the North‐West zone of Nigeria till March 2012.
He is a Faculty member for Harvard School of Public Health course on ‘Engineering Design for Airborne Infection Control course’ and also a facilitator on the Ahmadu Bello University & Obafemi Awolowo University Monitoring and Evaluation course organized in collaboration with Measure Evaluation.
He is presently the Senior Technical Advisor Program Management, KNCV/TB CARE I project Nigeria.
Dr Seema Meloni, Ph.D., M.P.H.
Dr Seema Meloni is a researcher in the Department of Immunology and Infectious Diseases at the Harvard School of Public Health and also an instructor at the Northeastern University Continuing Professional Studies program.
From 2006-2012, she was the Assistant Country Director for the Harvard PEPFAR Nigeria program and has over 7 years’ experience providing programmatic support to the scale-up of an HIV treatment program based in Nigeria, with emphasis on capacity building for electronic data management, monitoring and evaluation, and data use for improving quality of care.
Dr. Meloni has also conducted several program evaluations on ART and PMTCT outcomes, rates and predictors of loss and return to follow-up, HIV/HBV co-infection, HIV/HCV co-infection, and HIV drug resistance. She is presently working with HSPH colleagues on an NIH-funded grant to develop and apply modern techniques of mediation analysis to determine how much of a regimen’s success is due to treatment quality or patient adherence to the regimen.
She has over 20 articles published in peer-reviewed journals to her credit.
Prof DAVID OLALEYE
Professor David Olaleye holds DVM, M.Vet. Sc. (Diagn. Path.) and Ph.D. (Virology) from the University of Ibadan.
He has over 30 years working experience as a Lecturer and Researcher in Virology at the University of Ibadan and over 20 years as an Honorary Consultant Virologists to the University College hospital, Ibadan and the Federal Ministry of Health of Nigeria.
His research work has focused on the diagnosis and epidemiology of HIV and hepatitis viruses as well as respiratory, gastroenteritis, hemorrhagic fever and arthropod borne viruses in Nigeria.
He has collaborated on several research activities internationally and in Nigeria. His work at the Laboratory of Viral Oncology and AIDS Research, Department of Pathology, University of California, Los Angeles, USA led to the discovery of HIV-1 IbNg (now named CRFO2) in 1991.
He was the Principal Investigator of a WHO multinational project on epidemiology of respiratory syncytial virus among under-five children in Nigeria (1998-2000). He is currently Principal Investigator of the University of Ibadan NIH MEPIN program. He was a Mentor and member of training committee of the Northwestern University AIDS International Training Research Program (AITRP) in Nigeria. He has successfully supervised 14 Ph.D. candidates in Virology.
He has two chapters in a book and over 150 articles in peer reviewed scientific journals to his credit. He is an Adjunct Professor of Virology at Global Health Center, Feinberg School of Medicine, Northwestern University.
Professor Atiene Sagay
Prof Sagay is a Professor of Obstetrics and Gynecology and a lecturer in the same department at the University of Jos, Nigeria. Prof Sagay is the current chairman of the National PMTCT Task Team in Nigeria. He is a seasoned researcher with interests in Sexually Transmitted Infections, Cervical Cancer Screening, Virus infections, Family Planning and the Prevention of Mother-to-Child Transmission of HIV. He is the principal investigator of the JUTH Satellite APIN/PEPFAR program in Plateau state and the principal investigator of the University of Jos, Medical Education Partnership Initiative in Nigeria. He has over 65 articles published in peer reviewed journals to his credit.
Professor Folasade Ogunsola .FMCPath, FWACP, PhD.
Folasade Ogunsola is a professor of Medical Microbiology and the first female provost of the College of Medicine, University of Lagos. Her areas of interest include Infection Control, antibiotic resistance and sepsis. She also has an avid interest in infection control at the community level, especially prevention and treatment of sexually transmitted Infections including HIV among the very poor.
She is a seasoned researcher and has worked projects of public health relevance such as the FHI sponsored phase 3, clinical trial of a microbicide of Cellulose sulphate in HIV. She is the Principal Investigator for the Medical Education Partnership Initiative Nigeria (MEPIN), an National Institutes of Health (NIH) funded grant. She reviews for and serves on the Editorial board of a number of national and international peer reviewed scientific journals including the American Journal of Infection Control and West African Medical Journal.
She has consulted for the World Health Organization (WHO) since 2003 as an infection control expert. She is presently the Chairman of WHO working group on Infection Prevention and Control curriculum and a member of the WHO technical Working Group on Infection Prevention and Control. She is also a member of the WHO AFRO regional Rapid Response group of Experts for epidemics
She has published 70 papers in peer reviewed national and international journals, has presented papers at over 60 conferences, workshops and seminars both nationally and internationally.
Prof Isaac Adewole, MBBS, FMCOG, FWACS, FAS
Isaac Adewole is a professor of Obstetrics and Gynecology and the Vice Chancellor, University of Ibadan, Nigeria. He is the immediate past chairman of the of the National PMTCT Task Team in Nigeria
He is a seasoned academic and researcher; the Principal Investigator of the PEPFAR supported AIDS Prevention Initiative in Nigeria (APIN) Program at UCH co-Principal Investigator of the Medical Education Partnership Initiative of Nigeria (MEPIN). He is also the Principal Investigator for ‘Operation Stop Cervical Cancer’ in Nigeria. He is the Guttmacher Institute’s 2008 Bixby Leadership Fellow in Reproductive Health, President of African Organization for Research and Training in Cancer (AORTIC) and the current chair of the Sub-Saharan African Cervical Cancer Working Group (CCWG).
He has presented over 100 Conference papers in many parts of the world and has 20 Chapters in books and edited conference proceedings, and over 160 articles in leading peer-reviewed learned journals in his discipline. His publications are mainly in Gynaecological Oncology, Abortion/Reproductive Tract Infections/HIV-AIDS, and Perinatal Medicine.
He holds membership of many learned societies, including the Nigerian Medical Association, the Society of Gynaecology and Obstetrics of Nigeria, International Federation of Gynecology and Obstetrics (FIGO), International AIDS Society (IAS), and the International Gynecological Cancer Society (IGCS). He is a fellow of the prestigious Nigerian Academy of Science and member of the Ethics Committee of the International Agency for Research on Cancer (IARC) and the Governing Board of the Association of Commonwealth Universities (ACU).
Dr. Okey Nwanyanwu
Dr. Okey Nwanyanwu, joined CDC Nigeria as the Country Director in 2010. He brings with him extensive experience substantiated by his previous positions as CDC Country Director for Guyana and South Africa and his position as Senior Advisor for Global HIV/AIDS. He is an internationally recognized leader in the field of public health, epidemiology, malaria control, and HIV/AIDS prevention, care, and treatment. Dr. Okey Nwanyanwu holds a Bachelor of Science from the University of South Carolina and a Doctor of Public Health Degree from the University of Texas, School of Public Health.
Prof Phyllis Kanki BS, DVM, DSc
Phyllis Kanki is a Professor of Immunology and Infectious Diseases at the Harvard School of Public Health with vast research and program management experience working in sub-Saharan Africa (Nigeria, Tanzania, Botswana and Senegal). She is also an adjunct professor of Virology at the University of Ibadan and a visiting Professor of Medical Microbiology at the University of Jos, Jos, Nigeria
She contributed to ground breaking research that provided the initial characterization of HIV-2, demonstrated reduced virulence, transmission and progression to disease and interactions with HIV-1 subtypes from West Africa.
In Nigeria, she created and directed AIDS PREVENTION INITIATIVE IN NIGERIA (APIN) with a $25 million grant from the Bill & Melinda Gates Foundation and led the Harvard/PEPFAR program. This grant supported many M.P.H. and PhD scholarships for Nigerians, many of whom are back in Nigeria and contributing to the national response and overall national development. She was also the principal investigator of Harvard track 1 PEPFAR grants for 3 countries (Nigeria, Tanzania, and Botswana) which was awarded in 2008. The grant is the largest single PEPFAR grant awarded to the Harvard University.
She has mentored over 40 doctoral students and fellows from the US and African countries and has published over 190 articles in leading peer-reviewed journals
Prof Adesegun Fatusi
Adesegun Fatusi is a Professor of Public Health and Community Medicine and the Current Provost of the College of Health Sciences, Obafemi Awolowo University (OAU), Ile-Ife, Nigeria. He previously held the position of OAU’s Director of the Institute of Public Health, as well as the Director of Population & Reproductive Health Programme. Prior to joining the university, he worked as a Reproductive Health Advisor to UNFPA-supported programmes in Nigeria. His main areas of focus are: Adolescent Health & Development; Reproductive Health; Public Health Policy and Leadership.
Beyond the academia, he is well known for his frontline roles in leading national public health research initiatives, policy development and population-level programming. Among others, he has served as the lead consultant in developing several Nigerian policies, including the National Policy on the Health and Development of Adolescents and Young People, National Reproductive Health Policy, and National HIV/AIDS Policy. He is a member of the Lancet Commission on Adolescent Health and currently chairs Nigeria’s National Adolescent Health Working Group. He has worked as a consultant to several international development agencies, including UNFPA, UNICEF, WHO, World Bank, and USAID.